Commercialization A-Z Series
This webinar series addresses background information and common stumbling blocks for researchers and entrepreneurs in taking discoveries to patients.
Registration is free.
Session 2 -
Are You an Inventor, or Are You an Entrepreneur?
March 20, 2018 • Click for Recording
Russell Thomas, Co-Founder and CEO, NIRvana Sciences
Discussant: Nathan Anderson, Independent Consultant
Biopharma Strategy and Operations
Mr. Thomas is a second time start up CEO whose first venture involved commercializing a fluorescent dye analytical instrument. Prior to pursuing NIRvana Sciences, he was Director, New Ventures at NC State University. NIRvana Sciences is commercializing two families of dyes developed at NC State University: chlorins and bacteriochlorins.
Starting a new life science company is not for the faint of heart. In this presentation, we explore the dimensions of personality and energies that are expressed in the lab and as the driver of business. Without judgement, we ask you to consider the anticipated journeys that can help you determine your approach to commercializing your breakthroughs.
The role of the inventor in the start-up company is usually critical to the success of the new venture. However, inventors often do not understand the different roles available to them in a start-up -- and, the additional entrepreneurial help that is needed to realize their discoveries full potential. This discussion is designed to provide inventors with different perspectives, providing important information that can be used in all stages of a venture.
This webinar is well suited to those contemplating a start-up venture, in the early stages of a startup, or interested in understanding the fundamentals of the new venture process.
Nathan Anderson has prior experience evaluating technologies and recommending commercialization strategies as a part of Boston University’s Office of Technology Development and as a project manager for MassBio’s MassCONNECT program. He is currently an independent consultant interested in biopharmaceutical strategy and operations, as well as positioning scientific discoveries in a way favorable to realizing their potential.
Host: Joanne Gere, Executive Director, Westchester Biotech Project
Co-host: Joe Magno, CEO, NC COIN
Co-chair: Eileen M. Geoghegan, Ph.D., Research Fellow, Albert Einstein College of Medicine
Associate: Christopher Kinzel, Associate for Communication, Westchester Biotech Project